An overview of the
current data from PsoProtectMe

Current Data

We are committed to sharing data and are delighted to provide open access to summary information from PsoProtectMe. These data are preliminary so should not be used to inform clinical decision making.

Click here to read our research paper detailing PsoProtect data. A summary can be found on the Psoriasis Association website here.

Our research paper detailing shielding behaviour can be found here. A summary can also be found on the Psoriasis Association website here.

See our full list of research publications here.

PsoProtectMe surveys completed

Summary data from PsoProtectMe’s first 4501 participants.

Participants per country (≥10 participants):

Country Participants Country Participants
Argentina 217 Netherlands 35
Australia 38 Norway 21
Brazil 139 Panama 11
Canada 58 Paraguay 10
Chile 363 Peru 19
Denmark 51 Philippines 57
Dominican Republic 10 Poland 94
France 11 Portugal 204
Greece 13 Singapore 14
Hong Kong 18 South Africa 16
India 48 Spain 77
Ireland 60 Sweden 40
Italy 40 United Kingdom 2253
Japan 107 United States 317
Malaysia 10 Other (<10) 142
Mexico 10

Average age: 45 years (range 3-91)

Average BMI: 26.8 kg/m2

Type of psoriasis: 3721 plaque psoriasis, 950 guttate psoriasis, 251 pustular psoriasis, 93 erythrodema


Smoking status:

Coexisting psoriatic arthritis:

Type of psoriasis treatment:

Psoriasis severity change during the pandemic:

Have you been diagnosed with or thought you had COVID-19?

Did you go to hospital A&E due to your COVID-19?

Did you stay in hospital due to your COVID-19?

Has your COVID-19 infection got better?